How much bacteriostatic water with ipamorelin?
Most research-handling protocols use 2 mL of bacteriostatic water per 10 mg ipamorelin vial, yielding a 5 mg/mL working concentration. Ipamorelin dosing in research protocols typically uses 100-300 mcg per draw on a once-daily subcutaneous schedule, which 5 mg/mL accommodates at workable syringe units.
What the research literature says
Ipamorelin dosing across the published research literature typically uses per-draw amounts in the 100-300 mcg range on a once-daily or twice-daily subcutaneous schedule. The Raun characterisation work (PMID 9849822) and the Johansen pharmacokinetic study (PMID 9879640) covered the dose-response and pharmacokinetic framework that anchors typical research-protocol dose tiers.
For a 10 mg vial reconstituted with 2 mL of bacteriostatic water (5 mg/mL): a 100 mcg dose draws 2 units on an insulin syringe; 200 mcg draws 4 units; 300 mcg draws 6 units. The 1 mL reconstitution volume (10 mg/mL) is sometimes used for higher-concentration stocks but pushes the typical 100-200 mcg dose to 1-2 syringe units which sits at the lower edge of precision. The 2 mL fill is the typical pick because it keeps per-draw units in the easily-measurable range.
Ipamorelin’s ~2-hour plasma half-life supports daily or twice-daily dosing across multi-week research protocols. The combined CJC-1295 + Ipamorelin Blend format pairs ipamorelin with the GHRH-analogue arm for dual-receptor GH-axis engagement; the reconstitution math is similar at the per-vial level.
Why this matters in research context
Researchers running dose-titration protocols with ipamorelin need volume precision at the low-dose end (100 mcg) where 1-2 syringe units sits at the precision floor. The 2 mL fill is the standard choice because it elevates the lowest dose to 2 syringe units; 1 mL fills are reserved for protocols at higher dose tiers where the smaller per-draw volume is the operational priority.
Related compounds
- Ipamorelin 10mg — the compound covered by this answer
- CJC-1295 + Ipamorelin Blend — combined-formulation; reconstitution math similar at vial level
Related research questions
- What is the half-life of ipamorelin?
- Does ipamorelin raise cortisol?
- Can CJC-1295 be stacked with ipamorelin?
References
- Raun K et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol 1998;139(5):552-561. [PMID 9849822]
- Johansen PB et al. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption. Xenobiotica 1998;28(11):1083-1095. [PMID 9879640]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. Ipamorelin is sold strictly as a research-grade reagent for laboratory and bench research applications.